Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
Healthy Volunteers
NCT05332613

Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease

Led by Weill Medical College of Cornell University · Updated on 2026-02-27

40

Participants Needed

1

Research Sites

452 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will assess the impact of time-restricted eating (8 hours of eating each day) with standard of care lifestyle recommendations (hypocaloric, Mediterranean diet and 30 minutes of exercise on at least 5 days/week) on the degree of fat in the liver as measured by magnetic resonance imaging.

CONDITIONS

Official Title

Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to less than 65 years old
  • Provide signed written informed consent and agree to follow the study plan
  • Body mass index (BMI) greater than 25 kg/m²
  • Liver fat content of at least 10% measured by MRI-PDFF at the start of the study
Not Eligible

You will not qualify if you...

  • Unclear cause of liver disease
  • Other causes of liver fat accumulation
  • Other chronic liver diseases including hepatitis B, hepatitis C, drug-induced liver disease, alcoholic liver disease, autoimmune hepatitis, Wilson's disease, hemochromatosis, primary biliary cholangitis, or primary sclerosing cholangitis
  • Known or suspected liver cancer
  • Significant alcohol use in the past 5 years (more than 30g per day for men, more than 20g per day for women)
  • Cirrhosis or advanced liver fibrosis
  • Weight loss of 5% or more in the past 90 days
  • Regular fasting for 12 hours or more on most days
  • Pregnancy
  • Mental instability or inability to consent or follow the study
  • Unable to undergo MRI scans
  • Unable to safely perform prolonged fasting (such as those on insulin treatment)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Weill Cornell Medicine

New York, New York, United States, 10021

Actively Recruiting

Loading map...

Research Team

S

Sonal Kumar, MD

CONTACT

L

Lara Phipps

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease | DecenTrialz